Preclinical News and Research

RSS
Genocea commences GEN-003 Phase 1/2a study in moderate-to-severe HSV-2 infection

Genocea commences GEN-003 Phase 1/2a study in moderate-to-severe HSV-2 infection

Science Exchange launches Reproducibility Initiative

Science Exchange launches Reproducibility Initiative

Researchers solve hepatitis C vaccine mystery

Researchers solve hepatitis C vaccine mystery

CBIS initiates CS-TATI-1 GMP development plan

CBIS initiates CS-TATI-1 GMP development plan

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke

Combination of two existing pharmaceutical drugs shows promise against cocaine addiction

Combination of two existing pharmaceutical drugs shows promise against cocaine addiction

FDA approves label changes for Stryker Wingspan Stent System

FDA approves label changes for Stryker Wingspan Stent System

University of Nevada researcher to optimize new rapid test for melioidosis

University of Nevada researcher to optimize new rapid test for melioidosis

BioDiem granted European patent for antimicrobial drug

BioDiem granted European patent for antimicrobial drug

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Changes in monocytes are biomarker for amyotrophic lateral sclerosis

Changes in monocytes are biomarker for amyotrophic lateral sclerosis

New Translational Oncology Program at University of Michigan

New Translational Oncology Program at University of Michigan

Previously uncharacterized protein dramatically influences inflammation

Previously uncharacterized protein dramatically influences inflammation

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Drug molecules designed for influenza may be adapted to treat other viruses

Drug molecules designed for influenza may be adapted to treat other viruses

Potential PD biomarkers identified for sleep behavior disorder

Potential PD biomarkers identified for sleep behavior disorder

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

Researchers develop bioactive coating that actively suppresses brain's immune response

Researchers develop bioactive coating that actively suppresses brain's immune response

Researchers discover new approach to treat two lethal metastatic cancers

Researchers discover new approach to treat two lethal metastatic cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.